#1 Clinical Trials Search in Europe

Iloprost Trometamol

Iloprost Trometamol, a medication with diverse applications, is currently being studied in clinical trials for its potential benefits in bone healing and respiratory care. This article delves into two ongoing studies: one investigating its use in improving bone healing for patients with upper arm fractures, and another examining its effects on patients with infectious lung disease requiring mechanical ventilation. These trials aim to assess the safety and efficacy of Iloprost in these specific medical conditions, potentially opening new avenues for treatment.

Table of Contents

What is Iloprost Trometamol?

Iloprost Trometamol, also known simply as Iloprost, is a medication that belongs to a class of drugs called prostacyclin analogs. It is a synthetic compound that mimics the effects of a natural substance in your body called prostacyclin[1]. Prostacyclin helps to widen blood vessels and prevent blood clots. Iloprost is primarily used to treat various conditions related to blood circulation and has been the subject of recent clinical trials exploring its potential in other medical applications.

Medical Conditions Treated

Traditionally, Iloprost has been used to treat several medical conditions, including:

  • Pulmonary arterial hypertension: A condition where the blood pressure in the arteries of the lungs is too high
  • Raynaud’s phenomenon: A condition that affects blood flow to certain parts of the body, usually the fingers and toes
  • Scleroderma: A group of rare diseases that involve the hardening and tightening of the skin and connective tissues

Recent clinical trials are exploring the use of Iloprost in new areas, such as bone healing and respiratory conditions[1][2].

How is Iloprost Administered?

Iloprost is typically administered as an infusion, which means it’s given directly into the bloodstream through a vein. The medication comes in the form of a concentrate that is diluted and then given as a solution for infusion[1][2]. The exact dosage and duration of treatment can vary depending on the condition being treated and the individual patient’s needs.

Iloprost for Bone Healing

A recent clinical trial is investigating the use of Iloprost in improving bone healing for patients with upper arm (proximal humeral) fractures[1]. This study, known as the ILOBONE trial, is exploring a new application of Iloprost:

  • The medication is being applied locally at the fracture site during surgery
  • Researchers are studying if this method can promote better bone healing
  • The trial includes patients aged 40 to 80 years old who are undergoing surgery for specific types of upper arm fractures

This research could potentially open up new treatment options for patients with difficult-to-heal bone fractures.

Iloprost in Respiratory Conditions

Another ongoing clinical trial, called COMBAT-ARF, is investigating the use of Iloprost in patients with severe respiratory conditions[2]. This study is focusing on:

  • Patients with infectious pulmonary endotheliopathy, a condition where the infection affects the lining of blood vessels in the lungs
  • Adult patients who require mechanical ventilation (breathing support from a machine)
  • The potential of Iloprost to reduce mortality (death rates) in these severely ill patients

This research aims to determine if Iloprost can improve outcomes for patients with severe lung infections who require intensive care.

Safety Considerations

As with any medication, Iloprost has potential side effects and safety considerations. Some important points to note include:

  • Iloprost may not be suitable for patients with certain heart conditions, including severe coronary heart disease, unstable angina, or recent heart attacks[1]
  • It should be used cautiously in patients with a history of bleeding disorders or recent strokes[1][2]
  • Pregnant or breastfeeding women should consult their doctor before using Iloprost[1]
  • Some patients may have allergies to Iloprost or its ingredients[2]

Always consult with your healthcare provider about potential risks and benefits before starting any new medication.

Ongoing Research

The clinical trials mentioned in this article are part of ongoing research to expand our understanding of Iloprost’s potential uses. These studies are investigating:

  • The safety and effectiveness of Iloprost in new applications, such as bone healing and severe respiratory conditions[1][2]
  • Different methods of administering the drug, including local application at fracture sites[1]
  • The impact of Iloprost on patient outcomes, including mortality rates and recovery times[2]

As research continues, we may discover new ways that Iloprost can benefit patients with various medical conditions. It’s important to note that while these studies are promising, their results are not yet conclusive, and more research may be needed before any new uses for Iloprost are approved.

Aspect Bone Healing Study Respiratory Care Study
Condition Proximal humeral fracture Infectious pulmonary endotheliopathy
Main Objective Establish safety of Iloprost for bone healing Reduce 28-day mortality
Administration Local application at fracture site Continuous infusion for 72 hours
Key Inclusion Criteria Adults 40-80 years, specific fracture type Adult ICU patients, mechanical ventilation
Primary Endpoint Safety and toxicity assessment 28-day all-cause mortality

FAQ

  • What is Iloprost Trometamol? Iloprost Trometamol is a medication that belongs to a class of drugs called prostaglandins. It is being studied for its potential benefits in bone healing and respiratory care.
  • What conditions are being studied in these clinical trials? The clinical trials are focusing on two main conditions: proximal humeral fracture (upper arm bone fracture) and infectious pulmonary endotheliopathy (a lung condition in patients on mechanical ventilation).
  • How is Iloprost being administered in these trials? In the bone healing study, Iloprost is being applied locally at the fracture site. In the respiratory care study, it is being administered as a continuous infusion for 72 hours.
  • What are the main objectives of these clinical trials? The bone healing study aims to establish the safety of Iloprost for bone healing in upper arm fractures. The respiratory care study is investigating whether Iloprost can reduce 28-day mortality in patients with infectious lung disease on mechanical ventilation.
  • Who can participate in these clinical trials? Eligibility varies for each trial. The bone healing study includes adults aged 40-80 with specific types of upper arm fractures. The respiratory care study includes adult intensive care patients with suspected pulmonary infection and need for mechanical ventilation, among other criteria.

Ongoing Clinical Trials on Iloprost Trometamol

  • Study on the Effects of Iloprost Trometamol in Patients with Infectious Lung Disease on Mechanical Ventilation

    Recruiting

    2 1 1
    Investigated drugs:
    Denmark

  • Study on Iloprost for Improving Bone Healing in Patients with Upper Arm Fracture

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

Glossary

  • Proximal humeral fracture: A break in the upper part of the arm bone, near the shoulder joint.
  • PHILOS plate: A specialized surgical plate used to fix certain types of shoulder fractures.
  • ASA Score: A system used to assess a patient's physical status before surgery.
  • Infectious pulmonary endotheliopathy: A condition affecting the inner lining of blood vessels in the lungs due to infection.
  • Mechanical ventilation: The use of a machine to help a patient breathe when they cannot do so effectively on their own.
  • Endothelial biomarker (sTM): A substance in the blood that indicates the health of the blood vessel lining.
  • Septic shock: A severe condition where infection leads to dangerously low blood pressure and organ failure.
  • NYHA class: A classification system for heart failure symptoms, with class IV being the most severe.
  • Vasopressor: A medication used to raise blood pressure in critically ill patients.
  • Renal replacement therapy: A treatment that performs the function of the kidneys when they fail.

References

  1. http://clinicaltrials.eu/trial/study-on-iloprost-for-improving-bone-healing-in-patients-with-upper-arm-fracture/
  2. http://clinicaltrials.eu/trial/study-on-the-effects-of-iloprost-trometamol-in-patients-with-infectious-lung-disease-on-mechanical-ventilation/